Literature DB >> 34924892

Disease Clearance in Inflammatory Bowel Disease.

Jean-Frédéric Colombel1.   

Abstract

Entities:  

Year:  2021        PMID： 34924892      PMCID： PMC8667380     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?

Authors:  Manasi Agrawal; Jean-Frederic Colombel
Journal:  Gastrointest Endosc Clin N Am       Date:  2019-04-06

2.  Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.

Authors:  Toer W Stevens; Maria L Haasnoot; Geert R D'Haens; Christianne J Buskens; E Joline de Groof; Emma J Eshuis; Tjibbe J Gardenbroek; Bregje Mol; Pieter C F Stokkers; Willem A Bemelman; Cyriel Y Ponsioen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-06-30

3.  STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Authors:  Dan Turner; Amanda Ricciuto; Ayanna Lewis; Ferdinando D'Amico; Jasbir Dhaliwal; Anne M Griffiths; Dominik Bettenworth; William J Sandborn; Bruce E Sands; Walter Reinisch; Jürgen Schölmerich; Willem Bemelman; Silvio Danese; Jean Yves Mary; David Rubin; Jean-Frederic Colombel; Laurent Peyrin-Biroulet; Iris Dotan; Maria T Abreu; Axel Dignass
Journal:  Gastroenterology       Date:  2021-02-19       Impact factor: 22.682

4.  Evolving therapeutic goals in ulcerative colitis: towards disease clearance.

Authors:  Silvio Danese; Giulia Roda; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-01       Impact factor: 46.802

Review 5.  Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?

Authors:  Arianna Dal Buono; Giulia Roda; Marjorie Argollo; Eirini Zacharopoulou; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-08-18       Impact factor: 3.869
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.